Balyasny Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148M Sell
584,500
-16,349
-3% -$3.81M 0.19% 120
2026
Q1
$147M Buy
600,849
+561,069
+1,410% +$131M 0.19% 101
2025
Q4
$8.23M Sell
39,780
-151,667
-79% -$30M 0.01% 1126
2025
Q3
$35.5M Buy
191,447
+155,496
+433% +$26.6M 0.05% 484
2025
Q2
$5.49M Sell
35,951
-349,708
-91% -$53.8M 0.01% 1243
2025
Q1
$64M Buy
385,659
+103,326
+37% +$16.2M 0.11% 239
2024
Q4
$40.8M Buy
282,333
+171,201
+154% +$26.5M 0.06% 386
2024
Q3
$18M Buy
111,132
+105,722
+1,954% +$16.8M 0.03% 680
2024
Q2
$791K Sell
5,410
-26,422
-83% -$3.93M ﹤0.01% 1881
2024
Q1
$5.04M Buy
31,832
+8,691
+38% +$1.38M 0.01% 1219
2023
Q4
$3.63M Sell
23,141
-167,542
-88% -$25.7M 0.01% 1244
2023
Q3
$29.7M Buy
190,683
+180,173
+1,714% +$29.7M 0.06% 433
2023
Q2
$1.74M Sell
10,510
-63,381
-86% -$10.2M ﹤0.01% 1424
2023
Q1
$11.5M Buy
73,891
+73,769
+60,466% +$11.9M 0.03% 724
2022
Q4
$21.6K Sell
122
-9,577
-99% -$1.65M ﹤0.01% 2474
2022
Q3
$1.58M Buy
+9,699
New +$1.64M ﹤0.01% 1598
2022
Q2
Sell
-227,359
Closed -$40.5M 2957
2022
Q1
$40.3M Buy
+227,359
New +$38.7M 0.13% 198
2021
Q4
Sell
-586,748
Closed -$94.8M 2426
2021
Q3
$94.8M Buy
586,748
+241,466
+70% +$41.2M 0.39% 31
2021
Q2
$56.9M Buy
345,282
+146,059
+73% +$24.2M 0.27% 74
2021
Q1
$32.7M Sell
199,223
-37,000
-16% -$5.99M 0.16% 150
2020
Q4
$37.2M Buy
236,223
+70,450
+42% +$10.4M 0.21% 119
2020
Q3
$24.7M Sell
165,773
-22,128
-12% -$3.27M 0.18% 147
2020
Q2
$26.4M Buy
+187,901
New +$27.4M 0.23% 115
2020
Q1
Sell
-175,626
Closed -$24.9M 1334
2019
Q4
$25.6M Sell
175,626
-294,544
-63% -$40M 0.15% 203
2019
Q3
$60.8M Buy
470,170
+359,150
+324% +$47.3M 0.42% 41
2019
Q2
$15.5M Buy
111,020
+88,657
+396% +$12.3M 0.1% 284
2019
Q1
$3.13M Buy
+22,363
New +$3M 0.02% 702
2018
Q3
Sell
-12,619
Closed -$1.68M 1854
2018
Q2
$1.53M Buy
+12,619
New +$1.57M 0.01% 1022
2018
Q1
Sell
-107,858
Closed -$15.1M 2131
2017
Q4
$15.1M Sell
107,858
-327,399
-75% -$45.6M 0.05% 504
2017
Q3
$56.6M Buy
435,257
+382,904
+731% +$50.8M 0.22% 109
2017
Q2
$6.93M Sell
52,353
-245,002
-82% -$31.3M 0.03% 652
2017
Q1
$37M Buy
297,355
+255,255
+606% +$30.5M 0.17% 144
2016
Q4
$4.85M Buy
42,100
+37,616
+839% +$4.35M 0.03% 692
2016
Q3
$530K Sell
4,484
-355,275
-99% -$43.1M ﹤0.01% 740
2016
Q2
$43.6M Buy
359,759
+354,167
+6,333% +$40.2M 0.28% 90
2016
Q1
$605K Sell
5,592
-111
-2% -$11.5K ﹤0.01% 851
2015
Q4
$586K Sell
5,703
-77,846
-93% -$7.83M ﹤0.01% 800
2015
Q3
$7.8M Buy
+83,549
New +$8.08M 0.06% 411
2014
Q1
Sell
-112,661
Closed -$10.3M 616
2013
Q4
$10.3M Sell
112,661
-5,113
-4% -$471K 0.13% 195
2013
Q3
$10.2M Buy
+117,774
New +$10.6M 0.14% 196

Other funds holding JNJ

Balyasny Asset Management's JNJ Position: Q2 2026 in Review

Balyasny Asset Management reduced its Johnson & Johnson (JNJ) stake by 2.7% in Q2 2026, selling an estimated $3.81M and leaving 584,500 shares worth $148M. The position accounts for 0.19% of the portfolio, ranked #120.

Balyasny Asset Management first reported a position in JNJ in Q3 2013 and has held it in 40 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Balyasny Asset Management held 584,500 shares of Johnson & Johnson worth $148M as of Q2 2026.
  • Balyasny Asset Management sold 16,349 Johnson & Johnson shares in Q2 2026, an estimated $3.81M.
  • Johnson & Johnson made up 0.19% of Balyasny Asset Management's portfolio in Q2 2026, its #120 holding.
  • Balyasny Asset Management first reported a position in Johnson & Johnson in Q3 2013 and has held it in 40 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.